SC 13D
SC 13D Filing
- Company
- INTERPACE BIOSCIENCES, INC.
- Filed
- May 7, 2015
- Accession Number
- 0000892712-15-000550
A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →